Some heterozygous premature termination codon (PTC) mutations in COL6A1 cause Bethlem myopathy [76] but they are non-pathogenic when they occur in COL6A2/COL6A3 [6]. This evidence concerns the gene COL6A3 and Bethlem myopathy.